2022 (v1)
Publication
No description
Uploaded on: February 6, 2024
G
G
Last name: GUARALDI
First name: Giovanni
No description
Objectives: To report the 96 week results on efficacy, safety and bone mineral density (BMD) in subjects with HIV-1 that were virologically suppressed and treated with atazanavir/ritonavir monotherapy versus atazanavir/ ritonavir triple therapy. Methods: MODAt is a prospective, multicentre, open-label, non-inferiority, randomized, 96 week trial...